Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023).

Autor: Nakhaie, Mohsen, Farsangi, Sara Ahmadinejad, Zadeh Rukerd, Mohammad Rezaei, Shafieipour, Sara, Arefinia, Nasir, Zahedi, Mohammad Javad, Mahmoudvand, Shahab, Taheri, Ehsan, Charostad, Javad
Předmět:
Zdroj: Iranian Journal of Medical Microbiology; Nov/Dec2023, Vol. 17 Issue 6, p646-653, 8p
Abstrakt: Background and Aim: Viral infections are associated with augmented morbidity and mortality risk in Hemodialysis (HD) patients. Materials and Methods: In this investigation, we have scrutinized the presence of hepatitis B virus (HBV), and occult hepatitis B virus infection (OBI), in HD patients. In this cross-sectional study, the blood samples and data from 200 hemodialysis patients referred to a dialysis center in Kerman, from January 2022 to March 2023 were collected. Anti-HBV antibodies and HBs Ag were analyzed in the specimens using an enzyme-linked immunosorbent assay (ELISA). All samples were tested for OBI by using a real-time polymerase chain reaction (PCR) assay. Results: Of the 200 patients considered, 4 (2%) for HBs Ag were positive. Real-time PCR demonstrated OBI in 2 (1%) patients. The majority presence of viral infection was in the age group 50≥ years, self-employment, low education level, and diabetic patients. Furthermore, our study revealed that a higher percentage of HD patients were associated with low educational levels, self-employment, urban residence, and comorbidities such as diabetes and hypertension. Conclusion: In this study, HBV antigen prevalence was 2%, and OBI prevalence was 1%, indicating a low HBV incidence in HD patients. Our study underscores the importance of lifestyle improvement, increased awareness among lower-educated and lower-skilled individuals, and rigorous disinfection practices in managing risk factors for hemodialysis patients, including HBV and OBI. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index